AndhraNews.net
Home » Business News » 2013 » March » March 6, 2013

Bavarian Nordic to Host Full Year 2012 Conference Call


March 6, 2013 - London

KVISTGAARD, Denmark - March 6, 2013 - Bavarian Nordic A/S (OMX:BAVA) will announce its 2012 full year results on Tuesday, March 12, 2013.

The company will host a conference call at 2:00 pm CET (8:00 am EST) on the same day. Anders Hedegaard, President and CEO, will give a short presentation followed by a Q&A session. Additional participants from Bavarian Nordic are Paul Chaplin, Executive Vice President and Division President Infectious Diseases, James Breitmeyer, Executive Vice President and Division President Cancer Vaccines, Ole Larsen, Executive Vice President and CFO and Rolf Sass Sørensen, Vice President Investor Relations.

Dial-in numbers for the conference call are: Denmark: +45 32 72 80 18, UK: +44 (0) 844 571 8957, USA: +1 866 682 8490. For additional details please visit www.bavarian-nordic.com/webcast where also the accompanying presentation will be available in advance of the conference call.

A webcast of the conference call will be broadcast simultaneously at www.bavarian-nordic.com/webcast on a listen-only basis and will be available for replay subsequently.

About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's pipeline targets cancer and infectious diseases, and includes ten development programs. In oncology, the company's lead program is PROSTVAC®, a therapeutic vaccine candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial and is being developed under a collaboration agreement with the National Cancer Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC® has been tested in nearly 600 patients. In infectious diseases, the company's lead program is IMVAMUNE®, a third-generation smallpox vaccine candidate that is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. For more information, visit www.bavarian-nordic.com.

Contact
Rolf Sass Sørensen
Vice President Investor Relations & Communications
Phone: +45 33 26 83 83




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Bavarian Nordic A/S via Thomson Reuters ONE

HUG#1683308

GlobeNewswire

Comment on this story

Share